Angelini Ventures

Angelini Ventures operates as the strategic venture capital division of Angelini Industries, backed by a substantial €300 million capital commitment. The firm strategically identifies, develops, and invests in emerging companies pioneering breakthrough innovations across biotechnology, digital health, and life sciences sectors. With its robust financial foundation, Angelini Ventures aims to accelerate transformative healthcare solutions that address critical unmet needs while generating significant returns on investment.

The investment focus of Angelini Ventures demonstrates a specialized approach to healthcare innovation, with particular emphasis on brain health technologies and solutions serving specific consumer demographics including women, children, and elderly populations. This targeted strategy allows the firm to develop deep domain expertise in these high-growth segments while supporting companies whose missions align with evolving healthcare demands. Their portfolio typically includes early-stage to growth-phase companies developing novel therapeutics, diagnostic tools, digital health platforms, and medical technologies.

Headquartered in Rome, Italy, Angelini Ventures maintains a truly global operational footprint with team members strategically positioned across Europe, Asia, and the United States. This international presence provides portfolio companies with valuable cross-border perspectives, market access guidance, and extensive networking opportunities within the global healthcare ecosystem. The firm's diverse team brings together professionals with backgrounds spanning venture capital, pharmaceutical development, healthcare delivery, and technological innovation, offering portfolio companies multifaceted support beyond mere financial investment.

Beyond capital deployment, Angelini Ventures provides portfolio companies with comprehensive support including strategic guidance, regulatory navigation assistance, and access to Angelini Industries' extensive resources and expertise. The firm typically engages across multiple funding stages, from seed investments to later-stage growth capital, with a preference for companies demonstrating both scientific excellence and commercial viability. With its patient capital approach and long-term vision, Angelini Ventures has established itself as a valuable partner for healthcare innovators seeking to scale transformative solutions across international markets.